Gemcitabine and cisplatin salvage regimen in heavily pretreated metastatic breast cancer: a Brazilian experience Luiz Henrique de Lima AraújoMarcos Veloso MoitinhoHélio Noronha Júnior Original Paper 31 December 2010 Pages: 2 - 7
Predictors of mammography use in older women with disability: the patients’ perspectives Mabel CabanYong Fang KuoJean Freeman Original paper 21 September 2010 Pages: 8 - 14
Significance of vascular endothelial growth factor, interleukin-18 and nitric oxide in patients with breast cancer: correlation with carbohydrate antigen 15.3 Fatehya M. MetwallyHatem A. EL-mezayenHanaa H. Ahmed Original Paper 20 August 2010 Pages: 15 - 21
Whether drainage should be used after surgery for breast cancer? A systematic review of randomized controlled trials Xiao-Dong HeZhi-Hui GuoXiao-Dong Xie Original Paper 09 September 2010 Pages: 22 - 30
Evaluation of ER, PgR, HER-2, Ki-67, cyclin D1, and nm23-H1 as predictors of pathological complete response to neoadjuvant chemotherapy for locally advanced breast cancer Xi-ru LiMei LiuXin Song Original Paper 16 September 2010 Pages: 31 - 38
Phase III double-blind, placebo-controlled, prospective randomized trial of adjuvant tamoxifen vs. tamoxifen and fenretinide in postmenopausal women with positive receptors (EB193): an intergroup trial coordinated by the Eastern Cooperative Oncology Group Ruta D. RaoMelody A. CobleighWilliam C. Wood Original Paper 28 September 2010 Pages: 39 - 47
ER, PgR, HER-2, Ki-67, topoisomerase IIα, and nm23-H1 proteins expression as predictors of pathological complete response to neoadjuvant chemotherapy for locally advanced breast cancer Xi-ru LiMei LiuXin Song Original Paper 25 September 2010 Pages: 48 - 54
Bcl-2 expression and triple negative profile in breast carcinoma Imen Kallel-BayoudhHanen Ben HassenAhmed Rebaï OriginalPaper 02 October 2010 Pages: 55 - 61
Phyllodes tumor of the breast Grzegorz KorpantyDerek G. PowerJohn McCaffrey OriginalPaper 02 October 2010 Pages: 62 - 64
Taxane-based chemotherapy enhances response to neoadjuvant treatment for stage II and III breast cancer J. M. AndradeH. H. A. CarraraD. G. Tiezzi Original Paper 16 October 2010 Pages: 65 - 69
Health-related quality of life after chemotherapy cycle in breast cancer in Iran Peivand BastaniAliasghar Ahmad Kiadaliri Original Paper 26 October 2010 Pages: 70 - 74
Demographic and clinico-pathological characteristics in patients with triple-negative and non-triple-negative breast cancer Nilufer BulutSercan AksoyKadri Altundag Original Paper 21 October 2010 Pages: 75 - 79
Cardiac risk associated with the receipt of anthracycline and trastuzumab in a large nationwide cohort of older women with breast cancer, 1998–2005 Xianglin L. DuRui XiaChih-Chin Liu Original Paper 22 October 2010 Pages: 80 - 90
Effects of SMYD3 over-expression on cell cycle acceleration and cell proliferation in MDA-MB-231 human breast cancer cells Tian-nian RenJing-song WangTao Xi Original Paper 19 October 2010 Pages: 91 - 98
Oxymatrine diminishes the side population and inhibits the expression of β-catenin in MCF-7 breast cancer cells Ying ZhangBingkui PiaoHongsheng Lin Original paper 12 November 2010 Pages: 99 - 107
Significance of survivin and Bcl-2 homologous antagonist/killer mRNA in detection of bone metastasis in patients with breast cancer Samir F. ZohnyMohamed El-Shinawi Orginal Paper 27 October 2010 Pages: 108 - 114
Weekly ixabepilone administration in heavily pretreated metastatic breast cancer patients Ellen B. KossoffNuttapong NgamphaiboonTracey L. O’Connor Original Paper 27 October 2010 Pages: 115 - 120
Significance of epidermal growth factor receptor expression in breast cancer Tanja Badovinac-CrnjevicJasminka Jakic-RazumovicDamir Vrbanec Original Paper 23 November 2010 Pages: 121 - 128
CK5/6, EGFR, Ki-67, cyclin D1, and nm23-H1 protein expressions as predictors of pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancer patients Xi-ru LiMei LiuXin Song Original Paper 16 November 2010 Pages: 129 - 134
MCF-7/ADR cells (re-designated NCI/ADR-RES) are not derived from MCF-7 breast cancer cells: a loss for breast cancer multidrug-resistant research Weifeng KePei YuKe Li Original Paper 30 November 2010 Pages: 135 - 141
A phase II randomized study comparing navelbine and capecitabine (Navcap) followed either by Navcap or by weekly docetaxel in the first-line treatment of HER-2/neu negative metastatic breast cancer M. GhosnP. AftimosG. Chahine Original paper 07 December 2010 Pages: 142 - 151
Long-term outcome of a phase II study of docetaxel-based multimodality chemoradiotherapy for locally advanced carcinoma of the esophagus or gastroesophageal junction Nicholas W. ChoongAnn M. MauerEverett E. Vokes Original paper 21 August 2010 Pages: 152 - 161
Neurofibromatosis type 1-associated wild-type gastrointestinal stromal tumor treated with anti-IGF-1R monoclonal antibody F. L. DayJ. DesaiJ. Zalcberg Original Paper 27 August 2010 Pages: 162 - 164
Complete response after sorafenib therapy for hepatocellular carcinoma in an HIV-HBV co infected patient: Possible synergy with HAART ? A case report Leonidas ChelisNapoleon NtinosStylianos Kakolyris Original Paper 31 August 2010 Pages: 165 - 168
High-grade neuroendocrine carcinoma of the colon, long-term survival in advanced disease Derek G. PowerTimothy R. AsmisNancy E. Kemeny Review Article 14 September 2010 Pages: 169 - 174
The increase in the expression and hypomethylation of MUC4 gene with the progression of pancreatic ductal adenocarcinoma Yi ZhuJing-jing ZhangYi Miao Original paper 05 October 2010 Pages: 175 - 184
Prognostic factors and outcome of resected patients with gastrointestinal stromal tumors of small intestine Rong FanJie ZhongXiao-long Jin Original Paper 08 October 2010 Pages: 185 - 188
Down-regulation of miR-212 expression by DNA hypermethylation in human gastric cancer cells Ling XuFeng WangChuan-Yong Guo Original Paper 05 November 2010 Pages: 189 - 196
Overexpression of SGLT1 and EGFR in colorectal cancer showing a correlation with the prognosis Gui Fang GuoYu Chen CaiFang Wang Original Paper 17 November 2010 Pages: 197 - 203
Gastrointestinal stromal tumor of the rectum with bone and liver metastasis: a case study Yilmaz TezcanMehmet Koç original paper 17 October 2010 Pages: 204 - 206
MUC2 and MUC6 apomucins expression in human gastric neoplasm: an immunohistochemical analysis Abdul-Zaher M. KhattabWesam A. NasifMahmoud Lotfy OriginalPaper 29 September 2010 Pages: 207 - 213
Clinical significance of microsatellite instability for stage II or III colorectal cancer following adjuvant therapy with doxifluridine Byung Woog KangJong Gwang KimGyu-Seog Choi Original Paper 16 October 2010 Pages: 214 - 218
CIDE-3 interacts with lipopolysaccharide-induced tumor necrosis factor, and overexpression increases apoptosis in hepatocellular carcinoma Jie MinWei ZhangQing Li Original paper 19 October 2010 Pages: 219 - 227
Prognostic significance and mechanisms of patterned matrix vasculogenic mimicry in hepatocellular carcinoma Wen-bin LiuGe-liang XuXiu-jun Wang Original paper 19 October 2010 Pages: 228 - 238
Decreased expression of p39 is associated with a poor prognosis in human hepatocellular carcinoma Jeng-Wei LuJan-Gowth ChangRouh-Mei Hu Original Paper 09 October 2010 Pages: 239 - 245
Impressive efficacy of sorafenib in a patient with an hepatocellular carcinoma and a portal vein thrombosis associated with a metastatic ENT cancer Catherine LerouxElodie VauléonJean-Luc Raoul Original Paper 09 October 2010 Pages: 246 - 249
Primary gastric Hodgkin lymphoma and metachronous early gastric carcinoma: a case report Ayşe Gök DurnalıSaadet TokluoğluFatma Paksoy Türköz Case Report 22 October 2010 Pages: 250 - 252
Feasibility of cetuximab given with a simplified schedule every 2 weeks in advanced colorectal cancer: a multicenter, retrospective analysis M. BouchahdaT. MacarullaR. Guimbaud Original Paper 05 November 2010 Pages: 253 - 258
Diversity of axin in signaling pathways and its relation to colorectal cancer Nighat ParveenMahboob Ul HussainSyed Mudassar Original Paper 30 October 2010 Pages: 259 - 267
A relationship between ABO blood groups and clinicopathologic characteristics of patients with gastric adenocarcinoma in China Miao-Zhen QiuDong-Sheng ZhangRui-Hua Xu Original Paper 04 November 2010 Pages: 268 - 273
Postoperative chemoradiotherapy in gastric cancer: a phase I study of radiotherapy with dose escalation of oxaliplatin, 5-fluorouracil, and leucovorin (FOLFOX regimen) Xin WangYongsheng WangFeng Bi Original Paper 30 November 2010 Pages: 274 - 279
The functional polymorphism in monocyte chemoattractant protein-1 gene increases susceptibility to gastric cancer Haijuan GuMeixin NiBin Wang Original Paper 24 November 2010 Pages: 280 - 285
Hepatic artery chemoembolization for the treatment of liver metastases from neuroendocrine tumors: a long-term follow-up in 123 patients Xiang Da DongBrian I. Carr Original Paper 24 November 2010 Pages: 286 - 290
Salvage S-1 monotherapy in metastatic colorectal cancer patients who failed irinotecan-based or oxaliplatin-based chemotherapy Duk Joo LeeJeeyun LeeYoung Suk Park OriginalPaper 30 November 2010 Pages: 291 - 294
Evaluation of two modified ECF regimens in the treatment of advanced gallbladder cancer Jian Dong WangWei Bin ShiYong Yang Original paper 07 December 2010 Pages: 295 - 300
Slug inhibition upregulates radiation-induced PUMA activity leading to apoptosis in cholangiocarcinomas Kejun ZhangBingyuan ZhangChangyong Zhou Original Paper 01 December 2010 Pages: 301 - 309
Clinical outcome of panitumumab for metastatic colorectal cancer with wild-type KRAS status: a meta-analysis of randomized clinical trials Ezzeldin M. IbrahimKhaled M. Abouelkhair Original Paper 09 January 2011 Pages: 310 - 317
Extracellular matrix protein 1, a novel prognostic factor, is associated with metastatic potential of hepatocellular carcinoma Hao ChenWei-Dong JiaYong-Cang Wang OriginalPaper 03 December 2010 Pages: 318 - 325
EBV-LMP1-targeted DNAzyme restrains nasopharyngeal carcinoma growth in a mouse C666-1 xenograft model Xia KeYu-cheng YangSu-ling Hong Original Paper 24 September 2010 Pages: 326 - 332
